Global /Australia /Healthcare /Medical Devices /RHY

Rhythm Biosciences Ltd.

RHY

• ASX: RHY • Delayed

0.1350AUD -3.6%

0.0963 USD

As of 5 June 2026, Rhythm Biosciences Ltd. has a market cap of $35.35M USD, ranking #33098 globally and #865 in Australia. It ranks #2988 in the Healthcare sector, and #626 in the Medical Devices industry.

Global Rank

33098

Country Rank

865

Sector Rank

2988

Industry Rank

626

Key Stats

Market Cap

$35.35MUSD

49.54M AUD

Enterprise Value

$34.31MUSD

48.08M AUD

Revenue (TTM)

$1.18MUSD

1.65M AUD

EBITDA (TTM)

-$4.57MUSD

-6.4M AUD

Net Income (TTM)

-$4.76MUSD

-6.68M AUD

PS Ratio

30.1

PB Ratio

23.1

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Medical Devices

CEO

David Atkins open_in_new

Founded

2017

Website

rhythmbio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3.6%	-18%	-24%	-6.7%	46%	3.7%	112%	-71%	-87%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	RHY Rhythm Biosciences Ltd Ordinary Shares ISIN: AU000000RHY2 Shares Out.: Shares Outstanding: 364.06M¹ Shares Float: 323.676M² TV: TradingView: ASX: RHY SA: Stock Analysis: ASX: RHY YF: Yahoo Finance: RHY.AX GF: Google Finance: ASX: RHY BA: Barron's: RHY MS: Morningstar: XASX: RHY	0.1350 AUD	TV: TradingView: ASX: RHY SA: Stock Analysis: ASX: RHY YF: Yahoo Finance: RHY.AX GF: Google Finance: ASX: RHY BA: Barron's: RHY MS: Morningstar: XASX: RHY

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Rhythm Biosciences Ltd.

Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

Similar Companies

Industry: Medical Devices (Australia)

Name	Market Cap (USD) diff.	PE	Country
Cochlear Ltd. ASX: COH	$4.2B 5.89B AUD 12K%	17.1	Australia
EBOS Group Ltd. NZE: EBO	$2.55B 4.34B NZD 7K%	16.0	Australia
Clarity Pharmaceuticals Ltd. ASX: CU6	$786.34M 1.1B AUD 2K%	-	Australia
Nanosonics Ltd. ASX: NAN	$743.12M 1.04B AUD 2K%	52.3	Australia
Tetratherix Ltd. ASX: TTX	$171.0M 239.61M AUD 384%	-	Australia
Orthocell Ltd. ASX: OCC	$170.38M 238.75M AUD 382%	-	Australia

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 490K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 455K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 450K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 358K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 341K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 288K%	22.2	Ireland

chevron_leftBack